Skip to main content
Fig. 5 | Diagnostic Pathology

Fig. 5

From: Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Fig. 5

Technical experience of the DecisionDx-Melanoma test for samples submitted from March 2013 to June 2016. Quality control rejections, technical failures and successfully tested samples are presented for the time periods before and after the reduction in required tumor density, implemented after successful clinical validation and through educational efforts to improve biopsy tissue preservation at the dermatopathology level

Back to article page